vendredi 29 avril 2016

'Stop Hunting Zebras': What We Heard This Week

"It is now time to stop hunting zebras." -- Mindy Lefler, whose son has Duchenne muscular dystrophy, urging an FDA advisory panel to recommend approval of the investigational drug eteplirsen.

"These products can help [smokers] quit all tobacco use forever." -- John Britton, MD, head of a Royal College of Physicians (RCP) committee that endorsed e-cigarettes as stop-smoking aids.

"What this group is saying is not really relevant ... to the U.S. market." -- Erika Sward, American Lung Association spokesperson, on the RCP's statement.

"The question is how well, and how soon, and how precise can we be earlier on in, order to make a difference in peoples' lives." -- Madhukar Trivedi, MD, of the University of Texas Southwestern Medical Center in Dallas, during a CMS advisory committee meeting on treatment- resistant depression.

"I believe that for the first time, the FDA has given a drug accelerated status following a negative study." -- Paul Emery, MD, on a study of tocilizumab for systemic sclerosis.

"The mom changes the whole tone of family activities." -- Diana Ramos, MD, MPH, of the Los Angeles County health department, on a walking-based exercise program for new Hispanic mothers to help them lose weight gained during pregnancy.

"Physicians will have the opportunity to get paid more for investments that support patients, and do so with minimal burden." -- Andy Slavitt, acting administrator of the Centers for Medicare & Medicaid Services, discussing his agency's proposal to change the way physicians are reimbursed under Medicare.

"Do I want the FDA flying the plane, or a pilot who has 20 years experience?" -- Richard Fessler, MD, of Rush University Medical Center in Dallas, on the FDA's involvement in regulating how physicians prescribe opioids.

Let's block ads! (Why?)

'Stop Hunting Zebras': What We Heard This Week

Aucun commentaire:

Enregistrer un commentaire